|
31 December 2008
Progen and Avexa Merger Update
22 December 2008
Webcast: Progen and Avexa to Merge
22 December 2008
Merger of Progen and Avexa Presentation
22 December 2008
Progen and Avexa to Merge
10 December 2008
Company Secretary Resigns
5 December 2008
Notice of General Meeting/Proxy Form
24 November 2008
Results of Meeting
24 November 2008
Chairman's Address to Shareholders
24 November 2008
CEO's AGM Address
24 November 2008
Dr Stanley Chang - Withdrawl of Director Nomination
17 November 2008
Further Details on Capital Return to Shareholders
17 November 2008
Sale of PharmaSynth
14 November 2008
Requisition of General Meeting
13 November 2008
Strategy Recommendations & Board Response
12 November 2008
Resignation of Vice President Clinical & Medical Affairs
10 November 2008
Requisition of a General Meeting
23 October 2008
Progen's Annual Report 2008
23 October 2008
Progen AGM Documentation 2008
9 September 2008
Progen Receives NASDAQ Deficiency Notice
4 September 2008
Appendix 3Z - Prof John Zalcberg
4 September 2008
Progen restructures following wind-down of PATHWAY
28 August 2008
Progen Pharmaceuticals Announces Fiscal 2008 Financial Results
28 August 2008
Preliminary Final Report 30 June 2008
22 August 2008
Progen Appoints Corporate Advisor
14 August 2008
Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG11047, In Combination
11 August 2008
Shareholder Mail-Out
Click here for a copy of the newsletter
6 August 2008
Appendix 3B - New Issue Announcement
23 July 2008
Progen Terminates PATHWAY trial & confirms focus on potential high value molecules and M&A
2 July 2008
Progen Spins-Out Manufacturing Business
2 June 2008
Vice President of Research and Development Resignation
30 May 2008
Progen Presents on Epigenetics Platform at AACR
27 May 2008
Progen Corporate Presentation
19 May 2008
Progen Response to Media Coverage
15 May 2008
Progen Resumes Phase 1 Development of Anti-Cancer Agent PG11047
14 April 2008
Progen Presents PG500 Series at AACR Annual Conference San Diego
Click here for a copy of the poster
10 April 2008
New Issue Announcement
3 April 2008
New Issue Announcement
31 March 2008
New Issue Announcement
27 March 2008
Progen Restructures Manufacturing and Drug Discovery Divisions
19 March 2008
Progen Market Update - Response to Media Coverage
13 March 2008
Confirmation of Option Exercise Price
11 March 2008
Progen Announces Commencement of Global Phase 3 Trial
4 March 2008
Initial Director's Interest Notice
4 March 2008
Progen Expands Board of Directors
18 February 2008
Progen Half Yearly Results
13 February 2008
Phase 2 Preliminary Prostate Data
7 February 2008
Progen Closes Acquisition of Cellgate Inc
5 February 2008
Progen's Acquisition of Cellgate Teleconference
Click here to listen
4 February 2008
Cellgate Acquisition Presentation to Accompany Investor Teleconference
4 February 2008
Investor Teleconference dial-in details
4 February 2008
Cellgate Acquisition
1 February 2008
Financial Update
|